drugset / Trial / NCT07371325

Efficacy of Pediococcus Acidilactici as add-on to Antipsychotic Drugs on Metabolic Syndrome Disturbances in First-episode Psychosis and Schizophrenia Spectrum Disorders.

NCT07371325 ↗

RandomizedParallel-groupTriple-blindSupportive care

Summary

The aim of the present study is to evaluate the effectiveness of the addition of the postbiotic Pediococcus acidilactici (pA1c®HI) on amelioration of metabolic disturbances in patients with (FEP) or (SSD) treated with antipsychotic drugs.

Timeline

Start
2024-09-08
Primary completion
2026-01-23
Completion
2026-01-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Pediococcus acidilactici Other / unclassified — —